Advances in Cancer Research
By- George Vande Woude, Director, Van Andel Research Institute, Grand Rapids, MI, USA
The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents outstanding and original reviews on a variety of topics, including HAMLET and tumor cells; survivin and apoptosis control; retroviral insertional mutagenesis; aberrant ubiquitin-mediated proteolysis of cell cycle regulatory proteins and oncogenesis; and epigenetic variability and the evolution of human cancer.
Audience
Researchers and students in the basic and clinical science of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology, and molecular biology.
Advances in Cancer Research
Hardbound, 173 Pages
Published: March 2003
Imprint: Academic Press
ISBN: 978-0-12-006688-9
Reviews
-
"This classic and essential series presents critical overviews on select aspects of both cancer research and the basic underlying sciences" -AMERICAN SCIENTIST "Excellent, highly informative, in-depth reviews...expertly written, up-to-date, and well-referenced." -JOURNAL OF MEDICINAL CHEMISTRY "This is a series that has a long tradition of excellence in the field of cancer biology." -DOODY'S PUBLISHING REVIEWS
Contents
- HAMLET Kills Tumor Cells by Apoptosis - Cellular, Molecular and Therapeutic Aspects; Survivin and Apoptosis Control; Retroviral Insertional Mutagenesis: Tagging Cancer Pathways; Aberrant Ubiquitin-Mediated Proteolysis of Cell Cycle Regulatory Proteins and Oncogenesis; Epigenetic Variability and the Evolution of Human Cancer
